MK Bio Consultancy
↗Oss, Netherlands
MK Bio Consultancy is a strategic advisory firm providing specialized services to the pharmaceutical and biotechnology sectors. The company focuses on Chemistry, Manufacturing, and Controls (CMC) support, helping clients navigate the complexities of drug development from early-stage discovery through to commercial manufacturing.
The consultancy offers a range of services including vendor selection (CMO/CDMO identification), technical transfer management, scale-up strategies, and process validation. By leveraging deep expertise in biologics and nanobody technology, MK Bio Consultancy assists virtual and mid-sized biotechs in building investor-ready CMC roadmaps and ensuring regulatory compliance for clinical trials.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Biotech Consulting & CMC Services
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Bootstrapped
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:mAb, VHH (Nanobodies), Biologics, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:BioConnection B.V. (Strategic collaboration/shared leadership), PharmaSource (Training and workshop partner)
COMPETITION
Position:Niche Player
Competitors:Alacrita Consulting, BioProcess Technology Group (BPTG), PAREXEL Consulting
LEADERSHIP
Key Executives:
Marta Kijanka - Founder & Managing Director
Scientific Founders:Marta Kijanka
LINKS
Website:mkbioconsultancy.eu
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MK Bio Consultancy and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MK Bio Consultancy. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.